New Delhi: Mukupindura chikumbiro chaFresenius Medical Care, Specialty Expert Committee (SEC) yeCentral Drugs Standard Control Organisation (CDSCO) yakakurudzira kambani iyi kuti ipe zvikonzero zvekubvumidzwa pamwe chete nedata rekiriniki rechikamu chechitatu checalcium chloride dihydrate uye data rekutarisa mushure mekutengeswa kubva kunyika dzakatenderwa kuti zviongororwe zvakanyanya.
Kambani iyi yakamboisa chikumbiro chekugadzira nekutengesa calcium chloride dihydrate solution ine huwandu hwe100 mmol/L, iyo inoshandiswa "mukurapa kwekutsiva calcium mukurapa kwekutsiva itsvo (CRRT), dialysis (CLED) isingashande zvakanyanya (zuva nezuva) uye kurapa kuchinjana kweplasma (TPE) ne citrate anticoagulation. Chigadzirwa ichi chakakodzera vakuru nevana" uye chakataura zvikonzero zvekusabatanidzwa mumiedzo yekiriniki yechikamu chechitatu nechikamu chechina.
Komiti iyi yakaona kuti chigadzirwa ichi chakatenderwa munyika dzemuEurope dzakadai sePortugal, United Kingdom, Brazil, Switzerland, France neDenmark.
Karusiyamu chloride dihydrate iCaCl2 2H2O, inova calcium chloride ine mamorekuru maviri emvura payuniti imwe neimwe yecalcium chloride. Chinhu chichena chekristaro, chinonyungudika nyore nyore mumvura uye chinonyungudika, kureva kuti chinokwanisa kunwisa hunyoro kubva mumhepo.
Calcium chloride dihydrate chinhu chinogona kushandiswa senzira yekunyungudutsa chitin kana chanyungudutswa mu methanol. Chinoita basa rakakosha mukupwanya chimiro chekristaro chechitin uye chinoshandiswa zvakasiyana-siyana mumunda wekemesitiri.
Pamusangano weSEC Nephrology wakaitwa musi wa20 Chivabvu, 2025, boka rakaongorora chikumbiro chekubvumidza kugadzirwa nekutengeswa kwe100 mmol/L calcium chloride dihydrate infusion solution kuti ishandiswe mu "calcium replacement therapy mu continuous renal replacement therapy (CRRT), continuous low-efficiency (daily) dialysis (SLEDD), uye therapeutic plasma exchange (TPE) ne citrate anticoagulation. Chigadzirwa ichi chinoratidzwa muvanhu vakuru nevana" uye chakapa chikonzero chekusabatanidzwa mumiedzo yekiriniki ye phase III ne IV.
Mushure mekukurukurirana kwakadzama, komiti yakakurudzira kuti hwaro hwekubvumidzwa, pamwe nedata rechikamu chechitatu chekuyedzwa kwekiriniki uye data rekutarisa mushure mekutengeswa kubva kunyika dzakabvumidza mushonga uyu, zviendeswe kukomiti kuti zviongororwe zvakare.
Verenga zvakare: CDSCO Group Inotendera Kugadziriswa Kwazvino kweSanofi's Myozyme, Inokumbira Ongororo Yemutemo
Dr. Divya Kolin akapedza kudzidza kuPharmD ane ruzivo rwakakura mukurapa nechipatara uye hunyanzvi hwekuongorora nekurapa. Akashandawo semushonga wekenza mudhipatimendi rekenza paMysore Medical College and Research Institute. Pari zvino ari kuita basa rake mukutsvaga kwekiriniki uye manejimendi yedata rekiriniki. Anga achishanda neMedical Dialogue kubva muna Ndira 2022.
       Dr Kamal Kant Kohli, MBBS, MD, CP, is a thoracic specialist with over 30 years of experience and specializes in clinical writing. He joins Medical Dialogues as the Editor-in-Chief of Medical News. Apart from writing articles, as the Editor, he is responsible for proofreading and reviewing all medical content published in Medical Dialogues, including content from journals, research papers, medical conferences, guidelines, etc. Email: drkohli@medicaldialogues.in Contact: 011-43720751
Chidzidzo cheABYSS chakawana kuti kumisa beta-blockers mushure mekurwara nemwoyo kwakaguma nekuwedzera kweBP, kurova kwemoyo, uye zviitiko zvakaipa zvemwoyo: …